Predictive value of viral load and other markers for progression to clinical AIDS after CD4+ cell count falls below 200/μL

被引:16
作者
Carré, N
Boufassa, F
Hubert, JB
Chavance, M
Rouzioux, C
Goujard, C
Laurian, Y
Meyer, L
机构
[1] Hop Bicetre, INSERM, U292, F-94276 Le Kremlin Bicetre, France
[2] Hop Paul Brousse, INSERM, U169, Villejuif, France
[3] Hop Necker Enfants Malad, Serv Virol, Paris, France
[4] Hop Bicetre, Serv Med Interne, Le Kremlin Bicetre, France
[5] Hop Bicetre, Ctr Traitement Hemophilie, Le Kremlin Bicetre, France
关键词
CD4 < 200/mu L; AIDS onset; markers; viral load; exposure groups;
D O I
10.1093/ije/27.5.897
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background To assess the predictive value of biological and clinical events for progression to AIDS (1993 European classification) when the CD4+ cell count falls below 200/mu l (CD4 threshold) in different exposure groups. To investigate whether such markers remain predictive independently of the serum HIV-1 RNA level at the CD4 threshold. Methods The predictive value of biological and clinical events occurring during the 24 months prior to the occurrence of CD4 threshold (n = 333) was quantified in a Cox model. Another Cox model was carried out in a subset of 77 patients in whom viral load from stored sera was available. Furthermore, changes in viral load during the 24 months preceding the CD4 threshold were assessed in a mixed model according to subsequent development of AIDS. Results Among the 333 patients, the slope of the CD4+ cell counts, the emergence of p24 antigen, persistent thrush, and age at the CD4 threshold were independent predictors of progression to clinical AIDS (44.7%). Among the subset of 77 patients, the HIV-I RNA level at the CD4 threshold, persistent thrush and age remained independent predictors of progression to AIDS (45.5%). The increase of the HIV-I RNA level was moderate, both in non-progressors (24.0% per year) and in those who subsequently developed AIDS (27.1% per year), (P = 0.93). Viral load was consistently higher in the latter group (P = 0.002). Conclusion At a late stage of infection, age and persistent thrush remain predictive of progression to AIDS, independently of viral load.
引用
收藏
页码:897 / 903
页数:7
相关论文
共 36 条
[1]   INFLUENCE OF NEUROLOGIC MANIFESTATIONS OF PRIMARY HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION ON DISEASE PROGRESSION [J].
BOUFASSA, F ;
BACHMEYER, C ;
CARRE, N ;
DEVEAU, C ;
PERSOZ, A ;
JADAND, C ;
SERENI, D ;
BUCQUET, D ;
ROUZIOUX, C ;
DELLAMONICA, P ;
GALLAIS, H ;
DELFRAISSY, JF ;
LEFRERE, JJ ;
CASSUTO, JP ;
DUPONT, B ;
VITTECOQ, D ;
HERSON, S ;
GASTAUT, JA ;
VILDE, JL ;
KATLAMA, C ;
SOBEL, A ;
DUVAL, J ;
KAZATCHKINE, M ;
LEBRAS, P ;
EVEN, P ;
GUILLEVIN, L ;
MEYER, L ;
DEVEAU, C .
JOURNAL OF INFECTIOUS DISEASES, 1995, 171 (05) :1190-1195
[2]   HEMOCO: A French prospective study of hemophiliacs infected by human immunodeficiency virus type 1 (HIV-1) [J].
Boufassa, F ;
Carre, N ;
Deveau, C ;
Sultan, Y ;
Gazengel, C ;
Blanc, A ;
Peynet, J ;
Ramirez, D ;
Meyer, L ;
Stieltjes, N ;
Rothschild, C ;
Torchet, MF ;
Laurian, Y ;
dOiron, R ;
Rafowicz, A ;
Kebedjis, L ;
Laux, C .
HEMATOLOGY AND CELL THERAPY, 1996, 38 (02) :193-198
[3]  
BUCQUET D, 1994, PRESSE MED, V23, P1247
[4]   Antiretroviral therapy for HIV infection in 1996 - Recommendations of an international panel [J].
Carpenter, CCJ ;
Fischl, MA ;
Hammer, SM ;
Hirsch, MS ;
Jacobsen, DM ;
Katzenstein, DA ;
Montaner, JSG ;
Richman, DD ;
Saag, MS ;
Schooley, RT ;
Thompson, MA ;
Vella, S ;
Yeni, PG ;
Volberding, PA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 276 (02) :146-154
[5]   EFFECT OF AGE AND EXPOSURE GROUP ON THE ONSET OF AIDS IN HETEROSEXUAL AND HOMOSEXUAL HIV-INFECTED PATIENTS [J].
CARRE, N ;
DEVEAU, C ;
BELANGER, F ;
BOUFASSA, F ;
PERSOZ, A ;
JADAND, C ;
ROUZIOUX, C ;
DELFRAISSY, JF ;
BUCQUET, D ;
DELLAMONICA, P ;
GALLAIS, H ;
DORMONT, J ;
LEFRERE, JJ ;
CASSUTO, JP ;
DUPONT, B ;
VITTECOQ, D ;
HERSON, S ;
GASTAUT, JA ;
SERENI, D ;
VILDE, JL ;
BRUCKER, G ;
KATLAMA, C ;
SOBEL, A ;
DUVAL, J ;
KAZATCHINE, M ;
LEBRAS, P ;
EVEN, P ;
GUILLEVIN, L .
AIDS, 1994, 8 (06) :797-802
[6]   Association of plasma human immunodeficiency virus type 1 RNA level with risk of clinical progression in patients with advanced infection [J].
Coombs, RW ;
Welles, SL ;
Hooper, C ;
Reichelderfer, PS ;
DAquila, RT ;
Japour, AJ ;
Johnson, VA ;
Kuritzkes, DR ;
Richman, DD ;
Kwok, S ;
Todd, J ;
Jackson, JB ;
DeGruttola, V ;
Crumpacker, CS ;
Kahn, J .
JOURNAL OF INFECTIOUS DISEASES, 1996, 174 (04) :704-712
[7]  
Darby SC, 1996, LANCET, V347, P1573, DOI 10.1016/S0140-6736(96)91073-9
[8]   THE PROGNOSTIC VALUE OF CELLULAR AND SEROLOGIC MARKERS IN INFECTION WITH HUMAN IMMUNODEFICIENCY VIRUS TYPE-1 [J].
FAHEY, JL ;
TAYLOR, JMG ;
DETELS, R ;
HOFMANN, B ;
MELMED, R ;
NISHANIAN, P ;
GIORGI, JV .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 322 (03) :166-172
[9]   Virologic and serologic markers of rapid progression to AIDS after HIV-1 seroconversion [J].
Farzadegan, H ;
Henrard, DR ;
Kleeberger, CA ;
Schrager, L ;
Kirby, AJ ;
Saah, AJ ;
Rinaldo, CR ;
OGorman, M ;
Detels, R ;
Taylor, E ;
Phair, JP ;
Margolick, JB .
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1996, 13 (05) :448-455
[10]   THE HUMAN IMMUNODEFICIENCY VIRUS - INFECTIVITY AND MECHANISMS OF PATHOGENESIS [J].
FAUCI, AS .
SCIENCE, 1988, 239 (4840) :617-622